Whitehawk Therapeutics, Inc.: Form SCHEDULE 13D, filed Dec 31, 2024
Filed with the SEC on Dec 31, 2024 and accepted by EDGAR at Dec 31, 2024, 11:13 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001373604-24-000118. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.